These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 1535157)

  • 1. Overlap of the p53-responsive element and cAMP-responsive element in the enhancer of human T-cell leukemia virus type I.
    Aoyama N; Nagase T; Sawazaki T; Mizuguchi G; Nakagoshi H; Fujisawa JI; Yoshida M; Ishii S
    Proc Natl Acad Sci U S A; 1992 Jun; 89(12):5403-7. PubMed ID: 1535157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of cellular and viral promoters by mutant human p53 proteins found in tumor cells.
    Deb S; Jackson CT; Subler MA; Martin DW
    J Virol; 1992 Oct; 66(10):6164-70. PubMed ID: 1356162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new regulatory element that augments the Tax-dependent enhancer of human T-cell leukemia virus type 1 and cloning of cDNAs encoding its binding proteins.
    Tanimura A; Teshima H; Fujisawa J; Yoshida M
    J Virol; 1993 Sep; 67(9):5375-82. PubMed ID: 8350401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strong trans activation of the human cytomegalovirus major immediate-early enhancer by p40tax of human T-cell leukemia virus type I via two repetitive tax-responsive sequence elements.
    Moch H; Lang D; Stamminger T
    J Virol; 1992 Dec; 66(12):7346-54. PubMed ID: 1331524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the cyclic adenosine 3',5'-monophosphate response element in efficient expression of the rat thyrotropin receptor promoter.
    Ikuyama S; Shimura H; Hoeffler JP; Kohn LD
    Mol Endocrinol; 1992 Oct; 6(10):1701-15. PubMed ID: 1333054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The trans-activator tax of human T-cell leukemia virus type 1 (HTLV-1) interacts with cAMP-responsive element (CRE) binding and CRE modulator proteins that bind to the 21-base-pair enhancer of HTLV-1.
    Suzuki T; Fujisawa JI; Toita M; Yoshida M
    Proc Natl Acad Sci U S A; 1993 Jan; 90(2):610-4. PubMed ID: 8421695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HTLV-1 Tax has distinct but overlapping domains for transcriptional activation and for enhancer specificity.
    Fujii M; Tsuchiya H; Seiki M
    Oncogene; 1991 Dec; 6(12):2349-52. PubMed ID: 1766679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential activation of the 21-base-pair enhancer element of human T-cell leukemia virus type I by its own trans-activator and cyclic AMP.
    Nakamura M; Niki M; Ohtani K; Sugamura K
    Nucleic Acids Res; 1989 Jul; 17(13):5207-21. PubMed ID: 2548156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transactivation of the c-myc promoter by human T cell leukemia virus type 1 tax is mediated by NF kappa B.
    Duyao MP; Kessler DJ; Spicer DB; Bartholomew C; Cleveland JL; Siekevitz M; Sonenshein GE
    J Biol Chem; 1992 Aug; 267(23):16288-91. PubMed ID: 1644814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Interaction of p53 with p53 response element like binding sequence at upstream of hepatitis B virus enhancer I].
    Qu JH; Zhu MH; Lin J; Ni CR; Li FM; Zhu Z; Yu GZ
    Ai Zheng; 2004 May; 23(5):502-7. PubMed ID: 15142443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The core promoter region of the P-glycoprotein gene is sufficient to confer differential responsiveness to wild-type and mutant p53.
    Zastawny RL; Salvino R; Chen J; Benchimol S; Ling V
    Oncogene; 1993 Jun; 8(6):1529-35. PubMed ID: 8502478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The promoter of the latency-associated transcripts of herpes simplex virus type 1 contains a functional cAMP-response element: role of the latency-associated transcripts and cAMP in reactivation of viral latency.
    Leib DA; Nadeau KC; Rundle SA; Schaffer PA
    Proc Natl Acad Sci U S A; 1991 Jan; 88(1):48-52. PubMed ID: 1846042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The tumor suppressor p53 regulates its own transcription.
    Deffie A; Wu H; Reinke V; Lozano G
    Mol Cell Biol; 1993 Jun; 13(6):3415-23. PubMed ID: 7684498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Negative regulation of Rb expression by the p53 gene product.
    Shiio Y; Yamamoto T; Yamaguchi N
    Proc Natl Acad Sci U S A; 1992 Jun; 89(12):5206-10. PubMed ID: 1608930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of the IL-2 gene promoter by HTLV-I tax involves induction of NF-AT complexes bound to the CD28-responsive element.
    Good L; Maggirwar SB; Sun SC
    EMBO J; 1996 Jul; 15(14):3744-50. PubMed ID: 8670878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The MCK enhancer contains a p53 responsive element.
    Weintraub H; Hauschka S; Tapscott SJ
    Proc Natl Acad Sci U S A; 1991 Jun; 88(11):4570-1. PubMed ID: 1647009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multistep regulation of enhancer activity of the 21-base-pair element of human T-cell leukemia virus type I.
    Niki M; Ohtani K; Nakamura M; Sugamura K
    J Virol; 1992 Jul; 66(7):4348-57. PubMed ID: 1534852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tax protein of HTLV-1 inhibits CBP/p300-mediated transcription by interfering with recruitment of CBP/p300 onto DNA element of E-box or p53 binding site.
    Suzuki T; Uchida-Toita M; Yoshida M
    Oncogene; 1999 Jul; 18(28):4137-43. PubMed ID: 10435595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combinatorial control of the bradykinin B2 receptor promoter by p53, CREB, KLF-4, and CBP: implications for terminal nephron differentiation.
    Saifudeen Z; Dipp S; Fan H; El-Dahr SS
    Am J Physiol Renal Physiol; 2005 May; 288(5):F899-909. PubMed ID: 15632413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repression of glucocorticoid receptor transactivation and DNA binding of a glucocorticoid response element within the serum/glucocorticoid-inducible protein kinase (sgk) gene promoter by the p53 tumor suppressor protein.
    Maiyar AC; Phu PT; Huang AJ; Firestone GL
    Mol Endocrinol; 1997 Mar; 11(3):312-29. PubMed ID: 9058378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.